留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

2019年期刊公开发表的中国临床实践指南现状评价

杨楠 陈耀龙

杨楠, 陈耀龙. 2019年期刊公开发表的中国临床实践指南现状评价[J]. 协和医学杂志, 2021, 12(3): 407-410. doi: 10.12290/xhyxzz.2021-0323
引用本文: 杨楠, 陈耀龙. 2019年期刊公开发表的中国临床实践指南现状评价[J]. 协和医学杂志, 2021, 12(3): 407-410. doi: 10.12290/xhyxzz.2021-0323
YANG Nan, CHEN Yaolong. Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 407-410. doi: 10.12290/xhyxzz.2021-0323
Citation: YANG Nan, CHEN Yaolong. Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 407-410. doi: 10.12290/xhyxzz.2021-0323

2019年期刊公开发表的中国临床实践指南现状评价

doi: 10.12290/xhyxzz.2021-0323
详细信息
    通讯作者:

    陈耀龙 电话:0931-8912639,E-mail:chenyaolong@vip.163.com

  • 中图分类号: R181.2

Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019

More Information
  • 摘要: 调查2019年国内外期刊公开发表的中国临床实践指南现状,分别从制订人员、利益冲突、引文、证据质量和推荐强度分级、方法学质量与报告质量、研究空白、传播与实施7个方面进行分析,旨在为我国指南制订者、使用者和评价者提供参考。
    作者贡献:陈耀龙负责文章构思、结构设置及审校;杨楠、陈耀龙负责文章撰写。
    利益冲突  无
  • 图  1  1993—2018年中国期刊发表的指南数量[7-9]

  • [1] Institute of Medicine. Clinical Practice Guidelines We Can Trust[M]. Washington DC: The National Academies Press, 2011.
    [2] Grimshaw J, Russell I. Achieving health gain through clinical guidelines. I: Developing scientifically valid guidelines[J]. Qual Health Care, 1993, 2: 243-248. doi:  10.1136/qshc.2.4.243
    [3] Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations[J]. Lancet, 1993, 342: 1317-1322. doi:  10.1016/0140-6736(93)92244-N
    [4] Graham RP, James PA, Cowan TM. Are clinical practice guidelines valid for primary care?[J]. J Clin Epidemiol, 2000, 53: 949-954. doi:  10.1016/S0895-4356(99)00224-3
    [5] Oh SW, Lee HJ, Chin HJ, et al. Adherence to clinical practice guidelines and outcomes in diabetic patients[J]. Int J Qual Health Care, 2011, 23: 413-419. doi:  10.1093/intqhc/mzr036
    [6] Murad MH. Clinical practice guidelines: a primer on development and dissemination[J]. Mayo Clin Proc, 2017, 92: 423-433. doi:  10.1016/j.mayocp.2017.01.001
    [7] Chen YL, Yao L, Xiao XJ, et al. Quality assessment of clinical guidelines in China: 1993—2010[J]. Chin Med J(Engl), 2012, 125: 3660-3664. http://d.wanfangdata.com.cn/Periodical/zhcmj201220011
    [8] 王彦博, 王强, 赵明娟, 等. 2018年中国发布临床实践指南利益冲突与经济学证据的调查分析[J]. 医学新知杂志, 2020, 30: 139-158. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXZ202002009.htm

    Wang YB, Wang Q, Zhao MJ, et al. Conflict of interest and economic evidence in Chinese clinical practice guidelines published in 2018: A survey[J]. Yi Xue Xin Zhi Za Zhi, 2020, 30: 139-158. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXZ202002009.htm
    [9] 陈耀龙, 罗旭飞, 王吉耀, 等. 如何区分临床实践指南与专家共识[J]. 协和医学杂志, 2019, 10: 403-408. doi:  10.3969/j.issn.1674-9081.2019.04.018

    Chen YL, Luo XF, Wang JY, et al. How to Distinguish between Clinical Practice Guidelines and Expert Consensus[J]. Xie He Yi Xue Za Zhi, 2019, 10: 403-408. doi:  10.3969/j.issn.1674-9081.2019.04.018
    [10] 陈耀龙, 元博, 孙丽娜, 等. 中国大陆临床实践指南引文分析[J]. 中国循证儿科杂志, 2013, 8: 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201306021.htm

    Chen YL, Yuan B, Sun LN, et al. Citation analysis of clinical practice guidelines in mainland China[J]. Zhongguo Xun Zheng Er Ke Za Zhi, 2013, 8: 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201306021.htm
    [11] 王东珂. 中国临床实践指南证据质量与推荐强度分级标准调查[C]. 上海: 中国医师协会循证医学专业年会, 2018.
    [12] 陈耀龙, 王小琴, 吴琼芳, 等. 中国临床实践指南更新情况调查[J]. 中国循证医学杂志, 2014, 14: 178-183. doi:  10.7507/1672-2531.20140032

    Chen YL, Wang XQ, Wu QF, et al. Survey on Update Condition of Clinical Practice Guidelines in China[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2014, 14: 178-183. doi:  10.7507/1672-2531.20140032
    [13] 韦当, 王小琴, 吴琼芳, 等. 2011年中国临床实践指南质量评价[J]. 中国循证医学杂志, 2013, 13: 760-763. doi:  10.7507/1672-2531.20130134

    Wei D, Wang XQ, Wu QF, et al. Quality Evaluation on Chinese Clinical Practice Guidelines in 2011[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2013, 13: 760-763. doi:  10.7507/1672-2531.20130134
    [14] 李楠, 姚亮, 吴琼芳, 等. 2012—2013年中国大陆期刊发表临床实践指南质量评价[J]. 中国循证医学杂志, 2015, 15: 259-263. doi:  10.7507/1672-2531.20150045

    Li N, Yao L, Wu QF, et al. Quality Evaluation of Clinical Practice Guidelines Published in. Journals of Mainland China during 2012—2013[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2015;15: 259-263. doi:  10.7507/1672-2531.20150045
    [15] 王琪. 中国临床实践指南质量评价研究[D]. 兰州: 兰州大学, 2017.
    [16] 令娟, 王明霞, 王琪, 等. 2015年中国临床实践指南的报告质量分析[J]. 中国循证医学杂志, 2018, 18: 721-728. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201807014.htm

    Ling J, Wang MX, Wang Q, et al. Reporting quality of clinical practice guidelines of China in 2015[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2018, 18: 721-728. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201807014.htm
    [17] 柯立鑫, 王津京, 王浩, 等. 2016年中国大陆期刊发表临床实践指南的报告质量评价[J]. 中国循证儿科杂志, 2018, 13: 194-199. doi:  10.3969/j.issn.1673-5501.2018.03.008

    Ke LX, Wang JJ, Wang H, et al. Reporting quality evaluation of clinical practice guidelines published in journals of mainland China in 2016[J]. Zhongguo Xun Zheng Er Ke Za Zhi, 2018, 13: 194-199. doi:  10.3969/j.issn.1673-5501.2018.03.008
    [18] 杨钦博, 周奇, 黄天相, 等. 2017年中国大陆期刊发表的临床实践指南的报告质量评价[J]. 中国循证医学杂志, 2019, 19: 1325-1332. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201911011.htm

    Yang QB, Zhou Q, Huang TX, et al. Reporting quality of clinical practice guidelines. published in journals of mainland China in 2017[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2019, 19: 1325-1332. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201911011.htm
    [19] 王强, 黄超, 李俊, 等. 2017年中国发布的临床实践指南中利益冲突与经济学证据的调查分析[J]. 中国循证医学杂志, 2018, 18: 113-121.

    Wang Q, Huang C, Li J, et al. A survey of reporting status of conflict of interest and economic evidence in China's clinical practice guidelines published in 2017[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2018, 18: 113-121.
    [20] 张林, 赵明娟, 黄瑞秀, 等. 2017年中国发布的临床实践指南人员构成的分析[J]. 中国循证医学杂志, 2019, 19: 62-72. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201901011.htm

    Zhang L, Zhao MJ, Huang RX, et al. Reporting status of personnel composition and distribution in Chinese clinical practice guidelines published in 2017: a survey analysis[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2019, 19: 62-72. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201901011.htm
    [21] 陈耀龙, 商洪才, 杨克虎, 等. 临床实践指南的国际经验和中国道路[J]. 协和医学杂志, 2019, 10: 289-292. doi:  10.3969/j.issn.1674-9081.2019.03.018

    Chen YL, Shang HC, Yang KH, et al. International Experience and China's Route in Clinical Practice Guidelines[J]. Xie He Yi Xue Za Zhi, 2019, 10: 289-292. doi:  10.3969/j.issn.1674-9081.2019.03.018
    [22] Brouwers MC, Kho ME, Browman GP, et al. Appraisal of Guidelines for Research & Evaluationc Ⅱ[EB/OL ].[2020-07-31]. https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-II-Users-Manual-and-33-item-Instrument-2009-Update-2017.pdf.
    [23] Chen YL, Yang KH, Maruši c ' A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166: 128-132. doi:  10.7326/M16-1565
    [24] Iannone P, Montano N, Minardi M, et al. Wrong guidelines: why and how often they occur[J]. Evid Based Med, 2017, 22: 1-3. doi:  10.1136/ebmed-2016-110606
    [25] The Lancet. Managing conflicts of interests in clinical guidelines[J]. Lancet, 2019, 394: 710. http://www.ncbi.nlm.nih.gov/pubmed/31478486
    [26] Akl EA, Welch V, Pottie K, et al. GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development check-list[J]. J Clin Epidemiol, 2017, 90: 68-75. doi:  10.1016/j.jclinepi.2017.01.017
    [27] Bates SM, Ginsberg JS, Straus SE, et al. Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism[J]. CMAJ, 2000, 163: 1016-1021. http://europepmc.org/articles/PMC80552/
    [28] 陈耀龙, 王梦书, 李晓, 等. 卫生研究中证据的定义与循证规范[J]. 中国循证医学杂志, 2008, 8: 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ200812008.htm

    Chen YL, Wang MS, Li X, et al. Definition and evidence-based norms of evidence in health research[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2008, 8: 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ200812008.htm
    [29] World Health Organization. Box 3.1: Approach to rating the quality of evidence and strength of recommendations using the GRADE system[EB/OL ].[2021-04-12]. https://www.who.int/hiv/pub/guidelines/arv2013/intro/box3_1/en/.
    [30] Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations Ⅰ: Critical appraisal of existing approaches The GRADE Working Group[J]. BMC Health Serv Res, 2004, 4: 38. doi:  10.1186/1472-6963-4-38
    [31] Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines[J]. PLoS Med, 2010, 7: e1000217. doi:  10.1371/journal.pmed.1000217
    [32] Wang Q, Wang XQ, Chen YL, et al. Research Gap of guidelines might be an important approach to prioritization[J]. J Clin Epidemiol, 2016, 68: 251-252.
    [33] 马旭, 赵林华, 马琳, 等. 中国糖尿病防治相关指南基层推广现状分析[J]. 社区医学杂志, 2019, 17: 1167-1170. https://www.cnki.com.cn/Article/CJFDTOTAL-SQYX201919002.htm

    Ma X, Zhao LH, Ma L, et al. Current status of populariza-tion and application of relevant guidelines for diabetes prevention and treatment in China at grass-roots level[J]. She Qu Yi Xue Za Zhi, 2019, 17: 1167-1170. https://www.cnki.com.cn/Article/CJFDTOTAL-SQYX201919002.htm
    [34] Liu MY, Zhang C, Zha QL, et al. A national survey of Chinese medicine doctors and clinical practice guidelines in China[J]. BMC Complement Altern Med, 2017, 17: 451. doi:  10.1186/s12906-017-1946-2
  • 加载中
图(1)
计量
  • 文章访问数:  104
  • HTML全文浏览量:  20
  • PDF下载量:  21
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-04-12
  • 录用日期:  2021-05-07
  • 刊出日期:  2021-05-30

目录

    /

    返回文章
    返回